Search Results - "T Albarracin, Constance"

The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer by Song, Shumei, Honjo, Soichiro, Jin, Jiankang, Chang, Shih-Shin, Scott, Ailing W, Chen, Qiongrong, Kalhor, Neda, Correa, Arlene M, Hofstetter, Wayne L, Albarracin, Constance T, Wu, Tsung-Teh, Johnson, Randy L, Hung, Mien-Chie, Ajani, Jaffer A

“…Esophageal cancer is an aggressive malignancy and often resistant to therapy. Overexpression of EGFR has been associated with poor prognosis of patients with…”
Get full text

Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer by ATCHLEY, Deann P, ALBARRACIN, Constance T, LOPEZ, Adriana, VALERO, Vicente, AMOS, Christopher I, GONZALEZ-ANGULO, Ana Maria, HORTOBAGYI, Gabriel N, ARUN, Banu K

“…Mutations in the BRCA1 and BRCA2 genes confer greater risk of developing breast cancer. We determined whether tumor pathologic features and clinical features…”
Get full text

Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database by Wang, Jun, Wei, Bing, Albarracin, Constance T, Hu, Jianhua, Abraham, Susan C, Wu, Yun

“…Neuroendocrine carcinoma (NEC) of the breast is a rare type of carcinoma that has not been well studied or characterized. Of the limited number of studies…”
Get full text

The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer by Bhardwaj, Anjana, Singh, Harpreet, Trinidad, Celestine Marie, Albarracin, Constance T, Hunt, Kelly K, Bedrosian, Isabelle

“…Prevention of triple-negative breast cancer (TNBC) is hampered by lack of knowledge about the drivers of tumorigenesis. To identify molecular markers and their…”
Get full text

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling by Bhardwaj, Anjana, Ganesan, Nivetha, Tachibana, Kazunoshin, Rajapakshe, Kimal, Albarracin, Constance T, Gunaratne, Preethi H, Coarfa, Cristian, Bedrosian, Isabelle

“…Annexin A1 (ANXA1) is an anti-inflammatory protein reported to play a role in cell proliferation and apoptosis, and to be deregulated in breast cancer. The…”
Get full text

Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics by Cho, Woo Cheal, Ding, Qingqing, Wang, Wei‐Lien, Nagarajan, Priyadharsini, Curry, Jonathan L., Torres‐Cabala, Carlos A., Ivan, Doina, Albarracin, Constance T., Sahin, Aysegul, Prieto, Victor G., Aung, Phyu P.

“…Background Trichorhinophalangeal syndrome type 1 (TPRS1) expression has been found to be highly sensitive and specific for breast carcinomas. The frequency of…”
Get full text

Atypical Ductal Hyperplasia in Directional Vacuum-Assisted Biopsy of Breast Microcalcifications: Considerations for Surgical Excision by Nguyen, Christopher V., Albarracin, Constance T., Whitman, Gary J., Lopez, Adriana, Sneige, Nour

“…Background Our goal was to analyze clinicopathologic features of patients with atypical ductal hyperplasia (ADH) diagnosed on directional vacuum-assisted…”
Get full text

MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus by Maru, Dipen M, Singh, Rajesh R, Hannah, Christina, Albarracin, Constance T, Li, Yong X, Abraham, Ronald, Romans, Angela M, Yao, Hui, Luthra, Madan G, Anandasabapathy, Sharmila, Swisher, Stephen G, Hofstetter, Wayne L, Rashid, Asif, Luthra, Rajyalakshmi

“…Barrett's esophagus (BE)/Barrett's metaplasia (BM) is a recognized precursor of esophageal adenocarcinoma (EA) with an intermediary stage of dysplasia. The low…”
Get full text

Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field by KUERER, Henry M, ALBARRACIN, Constance T, BABIERA, Gildy, EDGERTON, Mary E, CZERNIECKI, Brian J, ARUN, Banu K, HORTOBAGYI, Gabriel N, YANG, Wei T, CARDIFF, Robert D, BREWSTER, Abenaa M, FRASER SYMMANS, W, HYLTON, Nola M, MIDDLETON, Lavinia P, KRISHNAMURTHY, Savitri, PERKINS, George H

“…Ductal carcinoma in situ (DCIS) is the fourth leading cancer for women in the United States. Understanding of the biology and clinical behavior of DCIS is…”
Get full text

Suppression of Akt-mTOR pathway-a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis by Bhardwaj, Anjana, Rosen, Daniel, Liu, Mei, Liu, Yan, Hao, Qiang, Ganesan, Nivetha, Etzel, Carol J, Gullett, Ashley, Albarracin, Constance T, Bedrosian, Isabelle

“…DNA damage has been thought to be directly associated with the neoplastic progression by enabling mutations in tumor suppressor genes and activating/and…”
Get full text

Pseudoangiomatous Stromal Hyperplasia of the Breast: Multimodality Review with Pathologic Correlation by Raj, Sean D., MD, Sahani, Vivek G., DO, JD, Adrada, Beatriz E., MD, Scoggins, Marion E., MD, Albarracin, Constance T., MD, PhD, Woodtichartpreecha, Piyanoot, MD, Posleman Monetto, Flavia E., MD, RDMS, Whitman, Gary J., MD

“…Pseudoangiomatous stromal hyperplasia (PASH) is a rare benign breast condition. PASH is thought to be hormonally responsive, and it is usually identified in…”
Get full text

Metastatic neuroendocrine tumour in the breast: a potential mimic of in-situ and invasive mammary carcinoma by Perry, Kyle D, Reynolds, Carol, Rosen, Daniel G, Edgerton, Mary E, T Albarracin, Constance, Gilcrease, Michael Z, Sahin, Aysegul A, Abraham, Susan C, Wu, Yun

“…Perry K D, Reynolds C, Rosen D G, Edgerton M E, Albarracin C T, Gilcrease M Z, Sahin A A, Abraham S C & Wu Y
(2011) Histopathology59, 619–630 Metastatic…”
Get full text

Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation by Tian, Zhen, MD, PhD, Wei, Bing, MD, Tang, Feng, MD, PhD, Wei, Wei, MS, Gilcrease, Michael Z., MD, PhD, Huo, Lei, MD, PhD, Albarracin, Constance T., MD, PhD, Resetkova, Erika, MD, PhD, Middleton, Lavinia, MD, Sahin, Aysegul, MD, Xing, Yan, MD, MPH, Hunt, Kelly K., MD, Chen, Jieqing, MD, Bu, Hong, MD, PhD, Rashid, Asif, MD, PhD, Abraham, Susan C., MD, Wu, Yun, MD, PhD

“…Summary Invasive mammary carcinoma with neuroendocrine differentiation has been controversial in terms of its definition and clinical outcome. In 2003, the…”
Get full text

Molecular cytogenetic characterization of mammary neuroendocrine carcinoma by Xiang, De-Bing, MD, PhD, Wei, Bing, MD, Abraham, Susan C., MD, Huo, Lei, MD, PhD, Albarracin, Constance T., MD, PhD, Zhang, Hong, MD, PhD, Babiera, Gildy, MD, Caudle, Abigail S., MD, Akay, Catherine L., MD, Rao, Pulivarthi, PhD, Zhao, Yi-Jue, PhD, Lu, Xinyan, MD, Wu, Yun, MD, PhD

“…Summary Primary mammary neuroendocrine carcinoma (NEC) is an uncommon entity that accounts for 2% to 5% of breast carcinomas. Recent reports have shown that…”
Get full text

Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome by Wang, Kim L, Wu, Tsung-Teh, Resetkova, Erika, Wang, Huamin, Correa, Arlene M, Hofstetter, Wayne L, Swisher, Stephen G, Ajani, Jaffer A, Rashid, Asif, Hamilton, Stanley R, Albarracin, Constance T

“…Purpose: Annexin A1 (ANXA1) is a calcium-binding protein involved in arachidonic acid metabolism and epidermal growth factor receptor tyrosine kinase pathway…”
Get full text

TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma by Yoon, Esther C., Wang, Gang, Parkinson, Bryce, Huo, Lei, Peng, Yan, Wang, Jing, Salisbury, Taylor, Wu, Yun, Chen, Hui, Albarracin, Constance T., Resetkova, Erika, Middleton, Lavinia P., Krishnamurthy, Savitri, Gan, Qiong, Sun, Hongxia, Huang, Xiao, Shen, Tiansheng, Chen, Wei, Parwani, Anil V., Sahin, Aysegul A., Li, Zaibo, Ding, Qingqing

“…A diagnostic dilemma can be encountered when primary triple-negative breast carcinoma (TNBC) without an in situ component or metastatic TNBCs lose the…”
Get full text

Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma by Ye, Qiqi, Chen, Hui, Han, Cody, Peng, Yan, Huang, Xiao, Sun, Hongxia, Wu, Yun, Albarracin, Constance T, Middleton, Lavinia P, Sahin, Aysegul A, Huo, Lei, Ding, Qingqing

“…Secretory carcinoma of breast (SCB) typically harbours gene fusion. Pan-Trk immunohistochemistry analysis (IHC) has been shown to be sensitive for SCB…”
Get more information

Loss of annexin A1 expression in breast cancer progression by Cao, Ying, Li, Yong, Edelweiss, Marcia, Arun, Banu, Rosen, Daniel, Resetkova, Erika, Wu, Yun, Liu, Jinsong, Sahin, Aysegul, Albarracin, Constance T

“…Annexin A1 (ANXA1) is a potential marker of development of breast cancer. However, previous studies of ANXA1 expression in primary breast carcinoma and lymph…”
Get full text

Pseudoangiomatous stromal hyperplasia tumor: a clinical, radiologic and pathologic study of 26 cases by Ferreira, Marco, Albarracin, Constance T, Resetkova, Erika

“…Pseudoangiomatous stromal hyperplasia tumors are rare. In this retrospective study, we evaluated the clinical, radiologic, and pathologic features of…”
Get full text

A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland by Salem, Alireza, Wu, Yun, Albarracin, Constance T., Middleton, Lavinia P., Kalhor, Neda, Peng, Yan, Huang, Xiao, Aung, Phyu P., Chen, Hui, Sahin, Aysegul A., Ding, Qingqing

“…GATA3 is the most used marker to determine tumors’ breast origin, but its diagnostic value in triple-negative breast cancer (TNBC) is limited. The newly…”
Get full text